Fig. 1 · Structure
Documents & Downloads
Benitrobenrazide
Hexokinase Inhibitor
Benitrobenrazide is a potent hexokinase 2 inhibitor, demonstrating an IC50 of 0.53 µM. This compound has been shown to induce DNA damage and exhibit significant antitumor activity, making it a valuable reagent for cancer research. Its ability to modulate cellular metabolism and promote apoptosis highlights its potential for therapeutic applications in oncology.
In Stock
Free Aliquoting for Your Order
Tell us your preferred amount per vial. We’ll confirm the options.
Specifications
| Manufacturer | Adooq Bioscience |
|---|---|
| Actions | Inhibitor |
| CAS Number | 2454676-05-0 |
| Applications | Hexokinase Inhibitor |
| Formula | C14H11N3O6 |
| Molecular Weight | 317.25 |
| Synonyms | BNBZ; Hexokinase 2 inhibitor 1 |
| SMILES | O=C(N/N=C/C1=CC=C(O)C(O)=C1O)C2=CC=C([N+]([O-])=O)C=C2 |
Storage & Solubility
In Vitro Solubility
Reported Solubility
No reported solubility data are available for this product.
Preparing Stock Solutions
| Concentration | |
|---|---|
Values use four significant digits. Prepare to the final solution volume; this is not the volume of solvent to add.
Stock preparation is unavailable for this product molecular weight.
Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.
Storage
Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.